On the other hand, when taking into consideration all genes from the main cluster of the cancer network (165), results significantly improve, as the identified gene DMD (dystrophin) is disrupted in the 21.13% of the registered cases of adenomas and adenocarcinomas with bronchus and lung as primary site, and also in the 16.35% squamous cell neoplasm cases at this same primary site, as it is shown in Figure 5. This evidence concerns the gene DMD and cancer.